Related Experiment Video
Updated: Jan 30, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Chronic kidney disease as a multidisciplinary problem of contemporary medicine
1I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University), Moscow, Russia.
Insights
Chronic kidney disease (CKD) affects nearly half of hypertensive patients in Russia. Early screening and interventions, like irbesartan, are vital for managing CKD and preventing cardiovascular complications.
Area of Science:
- Nephrology
- Cardiology
- Public Health
Background:
- Chronic kidney disease (CKD) is a significant health concern with a substantial impact on cardiovascular health.
- Epidemiological data from Russia indicates high prevalence of CKD markers in hypertensive individuals (49.4%).
- CKD shares common risk factors and pathogenetic mechanisms with hypertension, diabetes, and obesity.
Purpose of the Study:
- To review the multifaceted problem of chronic kidney disease (CKD) from both nephrological and cardiological perspectives.
- To highlight the relationship between the renal continuum and cardiovascular diseases.
- To emphasize the importance of early detection and intervention in CKD management.
Main Methods:
- Comprehensive literature review focusing on CKD epidemiology, risk factors, and pathogenesis.
- Discussion of current classification and glomerular filtration rate (GFR) calculation methods.
- Analysis of the renal continuum paradigm and its cardiovascular implications.
Main Results:
- CKD is a major contributor to mortality, primarily through cardiovascular complications.
- Hypertension, diabetes, and obesity are key drivers of CKD development and progression.
- Nephroprotective effects of angiotensin receptor blocker II (irbesartan) demonstrated potential for intervention in varying CKD severity.
Conclusions:
- Screening for renal dysfunction is necessary and justified due to the high prevalence and severe consequences of CKD.
- Understanding the renal continuum is crucial for managing patients at risk of cardiovascular events.
- Pharmacological interventions, such as irbesartan, show promise in mitigating CKD progression and associated cardiovascular risks.
Abstract:
A review deals with the problem of chronic kidney disease (CKD) from the position of a physician and cardiologist. The epidemiology of the disease was discussed both abroad and in Russia, including the most up-to-date data. In Russia CKD markers were detected in 49.4% of hypertensives. Authors describe risk factors and mechanisms of CKD at the most important pathogenetic conditions: hypertension, diabetes and obesity. The current classification and methods for calculating the glomerular filtration rate are given. The review disclose a paradigm of the renal continuum and its relation to cardiovascular diseases. It is well known fact that the final causes of the death of patients with CKD, as a rule, are cardiovascular complications. Based on the literature data, the necessity and expediency of screening for renal dysfunction is justified. In the example of use of an angiotensin receptor blocker II - irbesartan nephroprotective demonstrated possibilities of intervention in patients with renal dysfunction of varying severity.
More Related Videos
04:24Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease
Published on: September 5, 2025
05:34Author Spotlight: Utilizing Traditional Chinese Acupuncture of the Ear to Improve Sleep Disorders
Published on: August 18, 2023
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Contemporary Psychology
Biopsychology
Biopsychology, also known as biological psychology or behavioral neuroscience, focuses on the biological underpinnings of behavior and mental processes. It...
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...